| ||
| Claudio Bordignon member of the renewed ERC Scientific Council PharmaLive (press release) (subscription) ... NGR-hTNF, a novel vascular targeting agent (VTA), in Phase III in malignant pleural mesothelioma and in Phase II in six more indications: colorectal, lung (small-cell and non-small-cell), liver and ovarian cancer, and soft tissue sarcomas. ... See all stories on this topic » |
| ||
| Things Everyone Must Know About Non-Small Cell Lung Cancer | Uber ... 90% of all lung cancer patients are affected by non-small cell lung cancer. Non- small cell lung cancer is a combination of three distinct histologies ... uberarticles.com/.../things-everyone-must-know-about-non-sm... |
Tip: Use a plus sign (+) to match a term in your query exactly as is. Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment